Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PI3K/AKT/mTOR signalling inhibitor chrysophanol ameliorates neurobehavioural and neurochemical defects in propionic acid-induced experimental model of autism in adult rats
Aarti Sharma, Sonalika Bhalla, Sidharth Mehan
Metabolic Brain Disease (2022) Vol. 37, Iss. 6, pp. 1909-1929
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder
Shilu Deepa Thomas, Niraj Kumar Jha, Shreesh Ojha, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1889-1889
Open Access | Times Cited: 52
The Impact of Microglia on Neurodevelopment and Brain Function in Autism
Yuyi Luo, Zhengbo Wang
Biomedicines (2024) Vol. 12, Iss. 1, pp. 210-210
Open Access | Times Cited: 20
Icariin prevents methylmercury-induced experimental neurotoxicity: Evidence from cerebrospinal fluid, blood plasma, brain samples, and in-silico investigations
Sarthak Sharma, Sidharth Mehan, Zuber Khan, et al.
Heliyon (2024) Vol. 10, Iss. 1, pp. e24050-e24050
Open Access | Times Cited: 9
Nrf2/HO-1 Signaling Stimulation through Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) Provides Neuroprotection in Ethidium Bromide-Induced Experimental Model of Multiple Sclerosis
Shubham Upadhayay, Sidharth Mehan, Aradhana Prajapati, et al.
Genes (2022) Vol. 13, Iss. 8, pp. 1324-1324
Open Access | Times Cited: 30
Guggulsterone Selectively Modulates STAT-3, mTOR, and PPAR-Gamma Signaling in a Methylmercury-Exposed Experimental Neurotoxicity: Evidence from CSF, Blood Plasma, and Brain Samples
Sumit Kumar, Sidharth Mehan, Zuber Khan, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 8, pp. 5161-5193
Open Access | Times Cited: 7
Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity
Ambika Shandilya, Sidharth Mehan, Sumit Kumar, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3878-3878
Open Access | Times Cited: 24
Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder
Bidisha Rajkhowa, Sidharth Mehan, Pranshul Sethi, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 959-959
Open Access | Times Cited: 24
Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations
Swesha Chhabra, Sidharth Mehan, Zuber Khan, et al.
Journal of Neuroimmunology (2023) Vol. 384, pp. 578200-578200
Closed Access | Times Cited: 14
Disruptions in cellular communication: Molecular interplay between glutamate/NMDA signalling and MAPK pathways in neurological disorders
Sumedha Gupta, Abhishek Gupta, Sidharth Mehan, et al.
Neuroscience (2025)
Closed Access
Investigating the Interplay Between the Nrf2/Keap1/HO-1/SIRT-1 Pathway and the p75NTR/PI3K/Akt/MAPK Cascade in Neurological Disorders: Mechanistic Insights and Therapeutic Innovations
R Mukherjee, R.S. Rana, Sidharth Mehan, et al.
Molecular Neurobiology (2025)
Closed Access
Navigating the Complexities of Neuronal Signaling and Targets in Neurological Disorders: From Pathology to Therapeutics
Divya Choudhary, Muhammad Imran Khan, Zuber Khan, et al.
European Journal of Pharmacology (2025), pp. 177417-177417
Closed Access
Molecular mechanisms of GDNF/GFRA1/RET and PI3K/AKT/ERK signaling interplay in neuroprotection: Therapeutic strategies for treating neurological disorders
Manzar Khan, Divya Choudhary, Sidharth Mehan, et al.
Neuropeptides (2025) Vol. 111, pp. 102516-102516
Closed Access
Neuron-Specific Enolase (NSE) as a Biomarker for Autistic Spectrum Disease (ASD)
Felician Stancioiu, Raluca Bogdan, Radu Dumitrescu
Life (2023) Vol. 13, Iss. 8, pp. 1736-1736
Open Access | Times Cited: 9
Autism spectrum disorder and a possible role of anti-inflammatory treatments: experience in the pediatric allergy/immunology clinic
Harumi Jyonouchi
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Purmorphamine, a Smo-Shh/Gli Activator, Promotes Sonic Hedgehog-Mediated Neurogenesis and Restores Behavioural and Neurochemical Deficits in Experimental Model of Multiple Sclerosis
Aradhana Prajapati, Sidharth Mehan, Zuber Khan, et al.
Neurochemical Research (2023) Vol. 49, Iss. 6, pp. 1556-1576
Closed Access | Times Cited: 7
Neuroprotective potential of solanesol against tramadol induced zebrafish model of Parkinson’s disease: insights from neurobehavioral, molecular, and neurochemical evidence
Md Reyaz Alam, Vaishali Dobhal, Shamsher Singh
Drug and Chemical Toxicology (2024) Vol. 47, Iss. 6, pp. 1241-1256
Closed Access | Times Cited: 2
Therapeutic Potential of Oleanolic acid in Modulation of PI3K/Akt/mTOR/STAT-3/GSK-3β Signaling Pathways and Neuroprotection against Methylmercury-Induced Neurodegeneration
Ramaish Sharma, Sidharth Mehan, Zuber Khan, et al.
Neurochemistry International (2024) Vol. 180, pp. 105876-105876
Closed Access | Times Cited: 2
Melatonin-mediated IGF-1/GLP-1 activation in experimental OCD rats: Evidence from CSF, blood plasma, brain and in-silico investigations
Aditi Giri, Sidharth Mehan, Zuber Khan, et al.
Biochemical Pharmacology (2023) Vol. 217, pp. 115831-115831
Closed Access | Times Cited: 6
Interplay of G-proteins and Serotonin in the Neuroimmunoinflammatory Model of Chronic Stress and Depression: A Narrative Review
Evgeni Gusev, Alexey Sarapultsev
Current Pharmaceutical Design (2023) Vol. 30, Iss. 3, pp. 180-214
Closed Access | Times Cited: 5
Rapamycin Exerts an Antidepressant Effect and Enhances Myelination in the Prefrontal Cortex of Chronic Restraint Stress Mice
Jin Zhang, Weifen Li, Qi Yue, et al.
Neuroscience (2023) Vol. 535, pp. 99-107
Closed Access | Times Cited: 4
Synergistic promotion of angiogenesis after intracerebral hemorrhage by ginsenoside Rh2 and chrysophanol in rats
Mengying Li, Huifen Zhou, Zhiyong Pan, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107416-107416
Closed Access | Times Cited: 1
Exploring the transformative impact of traditional Chinese medicine on depression: Insights from animal models
Yan Yang, Yan-Kun Chen, Mengzhou Xie
World Journal of Psychiatry (2024) Vol. 14, Iss. 5, pp. 607-623
Open Access | Times Cited: 1
Synthesis and Neurobehavioral Evaluation of a Potent Multitargeted Inhibitor for the Treatment of Alzheimer’s Disease
Mohd Shahnawaz Khan, Zuber Khan, Nasimudeen R. Jabir, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 1
Therapeutic efficacy of Genistein in activation of neuronal AC/cAMP/CREB/PKA and mitochondrial ETC-Complex pathways in experimental model of autism: Evidence from CSF, blood plasma and brain analysis
Manjeet Kumar, Sidharth Mehan, Aakash Kumar, et al.
Brain Research (2024) Vol. 1846, pp. 149251-149251
Closed Access | Times Cited: 1
Neurogenic Effects of Inorganic Arsenic and Cdk5 Knockdown in Zebrafish Embryos: A Perspective on Modeling Autism
Qiang Gu, Jyotshna Kanungo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3459-3459
Open Access
Page 1 - Next Page

Scroll to top